financial estimates SomaLogic Reports Preliminary Q2 Revenues up 176 Percent The company projected Q2 revenues of $19.7 million and said the SEC had declared effective its proposed business combination with SPAC CM Life Sciences II. PerkinElmer to Acquire BioLegend for $5.25B; Q2 Revenues Rise 51 Percent The BioLegend deal, the largest in PerkinElmer's history, is expected to provide $.30 of adjusted earnings per share in the first full year following the close of the deal. Natera Reports Preliminary Q2 Revenue Growth of Around 60 Percent The company expects its women's health unit will be its first business to achieve cash flow breakeven operations in Q2. Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent The diagnostics segment was negatively impacted by supply chain issues with reagents causing back orders toward the end of the quarter. Qiagen Reports Preliminary Q2 Revenues Above Guidance; Adjusts FY21 Expectations Downward The company's preliminary revenues and EPS beat prior guidance and analysts' estimates as lower COVID-19 test sales were tempered by growth in core products. Apr 23, 2021 Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations Apr 14, 2021 Bruker Reports Preliminary Q1 Revenues of $549M to $554M, Beating Analyst Expectations Apr 5, 2021 HTG Molecular Preliminary Q1 Revenues Fall 56 Percent Feb 5, 2021 Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent Feb 2, 2021 PerkinElmer Q4 Revenues Spike 68 Percent Jan 13, 2021 Quanterix Provides Preliminary Results Projecting Q4 Revenues of $24M to $26M Jan 13, 2021 OpGen Preliminary Q4 Revenue Climbs 63 Percent Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 11, 2021 NanoString Technologies Expects Q4 Product and Service Revenues to Climb 6 Percent Jan 11, 2021 PacBio Reports Preliminary Q4 Revenues Above Wall Street Estimate Jan 11, 2021 Exact Sciences Reports Preliminary Q4 Revenues Up About 58 Percent Jan 11, 2021 CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates Jan 11, 2021 Invitae 2020 Preliminary Revenues Rise 28 Percent Jan 11, 2021 PerkinElmer Q4 Revenues Expected to Rise 66 Percent Jan 7, 2021 Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent Nov 5, 2020 Luminex Q3 Revenues Rise 35 Percent on Coronavirus Testing Demand Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 13, 2020 Qiagen Preliminary Q3 Revenues Up 26 Percent Oct 7, 2020 CareDx Preliminary Q3 Revenues Up 57 Percent Jul 28, 2020 PerkinElmer Q2 Revenues Up 12 Percent Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.